Joshua Pinto - Aug 27, 2024 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Signature
/s/ Joshua Pinto
Stock symbol
NMRA
Transactions as of
Aug 27, 2024
Transactions value $
-$178,806
Form type
4
Date filed
8/27/2024, 05:58 PM
Previous filing
Aug 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMRA Common Stock Sale -$179K -15.7K -10.15% $11.39 139K Aug 27, 2024 See footnote F1, F2, F3
holding NMRA Common Stock 85K Aug 27, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on April 18, 2024 and subsequently amended on May 22, 2024.
F2 This transaction was executed in multiple trades at prices ranging from $11.1572 to $11.58, inclusive. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Shares held by Maple DE Holdings LLC.